Data on the real-world effectiveness and impact of the COVID-19 vaccines.
Related Organizations
- Published in
- United Kingdom
Table of Contents
- Executive summary 3 2
- Vaccine effectiveness 3 2
- Population impact 3 2
- Vaccine effectiveness 5 2
- Effectiveness against symptomatic disease 6 2
- Effectiveness against hospitalisation 8 2
- Effectiveness against mortality 10 2
- Effectiveness against infection 11 2
- Effectiveness against transmission 11 2
- Vaccine effectiveness against the Omicron variant 13 2
- Population impact 19 2
- Vaccine coverage 19 2
- Vaccination in immunosuppressed individuals 23 2
- Vaccination in pregnancy 24 2
- Vaccination status in cases, deaths and hospitalisations 33 2
- Vaccine impact on proportion of population with antibodies to COVID-19 42 2
- Summary of impact on hospitalisations, infections and mortality 49 2
- References 50 2
- About the UK Health Security Agency 53 2
- Executive summary 2
- Vaccine effectiveness 3
- Population impact 3
- Vaccine effectiveness 5
- Effectiveness against symptomatic disease 6
- Effectiveness against hospitalisation 8
- Effectiveness against mortality 10
- Effectiveness against infection 11
- Effectiveness against transmission 11
- Table 1. Summary of evidence on vaccine effectiveness against different outcomes Delta 12
- Vaccine effectiveness against the Omicron variant 13
- Table 2. UKHSA publications on the effectiveness of COVID-19 vaccination 17
- Population impact 19
- Vaccine coverage 19
- Figure 7. Cumulative weekly vaccine uptake by age 20
- Vaccination in immunosuppressed individuals 23
- Vaccination in pregnancy 24
- Vaccine coverage 25
- Table 4. Overall vaccine coverage in women giving birth, by month of delivery 25
- Table 5. Vaccine coverage by ethnicity, for women giving birth June to August 2021 26
- Table 6. Vaccine coverage by quintile of deprivation of the small area in which the woman lived, for women giving birth June to August 2021 26
- Table 7. Vaccine coverage by age of mother, for women giving birth June to August 2021 26
- Methods 27
- Pregnancy outcomes 28
- Figure 8. Stillbirths experienced by women giving birth January to August 2021 28
- Figure 9. Low birthweight births, women giving birth January to August 2021 29
- Figure 10. Premature births in women giving birth January to August 2021 30
- Methods 30
- Main findings 31
- Vaccination status in cases, deaths and hospitalisations 33
- Methods 33
- Results 34
- Interpretation of data 34
- Table 8. COVID-19 cases by vaccination status between week 47 and week 50 2021 36
- Please note that corresponding rates by vaccination status can be found in Table 11. 36
- Table 9. COVID-19 cases presenting to emergency care (within 28 days of a positive specimen) resulting in an overnight inpatient admission by vaccination status between week 47 and week 50 2021 37
- Please note that corresponding rates by vaccination status can be found in Table 11. 37
- Table 10. COVID-19 deaths (a) within 28 days and (b) within 60 days of positive specimen or with COVID-19 reported on death certificate, by vaccination status between week 47 and week 50 2021 Please note that corresponding rates by vaccination status ... 38
- Vaccine impact on proportion of population with antibodies to COVID-19 42
- Seroprevalence 42
- Seroprevalence in blood donors aged 17 years and older 42
- National prevalence 43
- Figure 11. Overall 12-weekly rolling SARS-CoV-2 antibody seroprevalence (% seropositive) in blood donors. 43
- Regional prevalence of infection over time 44
- Prevalence by age group 45
- Roche S levels by age group and month 47
- Summary of impact on hospitalisations, infections and mortality 49
- References 50
- About the UK Health Security Agency 53
